Open AccessPhosphazide (nikavir) is a highly effective drug for the treatment of HIV/AIDS infection
Author(s) -
Г. А. Галегов
Publication year - 2017
Publication title -
voprosy virusologii
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.151
H-Index - 15
eISSN - 2411-2097
pISSN - 0507-4088
DOI - 10.18821/0507-4088-2017-62-1-5-11
Subject(s) - tolerability , medicine , human immunodeficiency virus (hiv) , antiretroviral therapy , tuberculosis , drug , immunology , transmission (telecommunications) , virology , viral load , pharmacology , pathology , adverse effect , electrical engineering , engineering
Federation Convincing evidence for high therapeutic activity and tolerability of Phosphazide in the treatment of HIV/AIDS-infection is given. Phosphazide is currently used in various regimens of highly active antiretroviral therapy, as well as in the HIV therapy in patients with simultaneously acquired chronic hepatitis C or tuberculosis. Therapeutic possibilities of Phosphazide were clearly manifested in the prevention of HIV transmission from mother to child. There is every reason to use Phosphazide in first-line antiretroviral therapy.